Back To TOP

Learn About Us

At Genentech, we develop medicines for serious or life-threatening medical conditions and we believe they should be accessible for the patients who need them.

 

 

 

  • Last year, we helped more than 100,000 fully insured, underinsured and uninsured patients with access issues
  • Every year, we support privately insured patients through our co-pay card programs
  • We have supported co-pay assistance foundations with more than $932* million in donations since 2005
  • Since 1985, when its first product was approved, Genentech has donated $3.50 billion in free medicine through the Genentech® Access to Care Foundation (GATCF) and other product donation programs

 

ZELBORAF Access Solutions

ZELBORAF Access Solutions offers a full range of programs and services to meet the needs of patients and health care professionals. We provide what patients need for access, from benefits investigations through patient assistance options.Learn more

 

* Amount is approximate pending final financial audit confirmation; data published in March 2013.
GATCF donation value is based on the most current forecast.
Learn More About
ZELBORAF
  • LEARN about treatment with ZELBORAF
  • FIND the right patient assistance program with our Compass for Patient Access tool
  • LEARN HOW the Genentech BioOncology Co-pay Card can help with the out-of-pocket costs for ZELBORAF
  • Download: new forms for enrollment in GATCF
  • Form Statement of Medical Necessity
  • Form Patient Authorization and Notice of Release of Information

The Access Solutions logo is a registered trademark of Genentech, Inc.